Quest Diagnostics Incorporated (DGX)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 136.34 |
| Open | 136.66 |
| Bid | 136.77 x 800 |
| Ask | 136.80 x 1100 |
| Day's Range | 135.26 - 137.46 |
| 52 Week Range | 119.59 - 145.58 |
| Volume | |
| Avg. Volume | 1,030,177 |
| Market Cap | 15.262B |
| Beta (5Y Monthly) | 0.89 |
| PE Ratio (TTM) | 18.49 |
| EPS (TTM) | 7.43 |
| Earnings Date | Jul 24, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | 3.00 (2.18%) |
| Ex-Dividend Date | Apr 05, 2024 |
| 1y Target Est | 147.00 |
ZacksReasons to Retain Quest Diagnostics (DGX) Stock for Now
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
ZacksQuest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
ACCESSWIREQuest Supports Expansion of Community Center and Provides No-Cost Wellness Testing to Newark Faith Community
NORTHAMPTON, MA / ACCESSWIRE / May 2, 2024 / Quest Diagnostics: At a glance: Quest worked with St. James Health in Newark to provide no-cost Blueprint for Wellness® screenings during a Choose Healthy Life event to celebrate expansion of Newark, NJ-based ...
© 2024 Yahoo. All rights reserved.